Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group

Gynecologic Oncology

Volumn 89, Issue 3, 2003, Pages 343-353

  Keys, Henry M ^a,i   Bundy, Brian N ^b   Stehman, Frederick B ^c   Okagaki, Takashi ^d   Gallup, Donald G ^e   Burnett, Alexander F ^f   Rotman, Marvin Z ^g   Fowler Jr , Wesley C ^h  

^a ALBANY MEDICAL COLLEGE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ Fox Cancer Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER CYTODIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; NEUROTOXICITY; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; RADIATION CARCINOGENESIS; RADICAL HYSTERECTOMY; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; ULTRAVIOLET IRRADIATION; UROGENITAL TRACT DISEASE; UTERINE CERVIX CARCINOMA;

EID: 0037836120     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00173-2     Document Type: Conference Paper

References (31)

1. Durrance F.Y., Fletcher G.H., Rutledge F.N. Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus. Am J Roentgenol Radiat Ther Nucl Med. 106:1969;831-838.
2. Jampolis S., Andras E.J., Fletcher G.H. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology. 115:1975;681-685.
3. Nelson A.J., Fletcher G.H., Wharton J.T. Indications for adjunctive conservative extrafascial hysterectomy in selected cases of carcinoma of the uterine cervix. Am J Roentgenol Radiat Ther Nucl Med. 123:1975;91-99.
4. Rutledge F.N., Wharton J.T., Fletcher G.H. Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix. Cancer. 38:1976;596-602.
5. Gallion H.H., van Nagell J.R., Donaldson E.S., Hanson M.B., Powell D.E., Maruyama Y., et al. Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer. 56:1985;262-265.
6. Russell A.H., Burt A.R., EK M., Russell K.J., Cain J.M., Greer B.E., et al. Adjunctive hysterectomy following radiation therapy for bulky carcinoma of the uterine cervix prognostic implications of tumor persistence . Gynecol Oncol. 28:1987;220-224.
7. Rotman M., John M.J., Moon S.H., Choi K.N., Stowe S.M., Abitbol A., et al. Limitations of adjunctive surgery in carcinoma of the cervix. Int J Radial Oncol Biol Phys. 5:1979;327-332.
8. Perez C.A., Breaux S., Askin F., Camel H.M., Powers W.E. Irradiation alone or in combination with surgery in stage IB and IIA carcinoma of the uterine cervix. Cancer. 43:1979;1062-1072.
9. Homesley H.D., Raben M., Blake D.D., Ferree C.R., Bullock M.S., Linton E.B., et al. Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Obstet. 150:1980;529-531.
10. O'Quinn A.G., Fletcher G.H., Wharton J.T. Guidelines for conservative hysterectomy after irradiation. Gynecol Oncol. 9:1980;68-79.
11. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks New representations of old estimators . Stat Med. 18:1999;695-706.
12. Rubenstein L.F., Gail M.H., Santner T.J. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chronic Dis. 34:1981;469-479.
13. Schoenfeld D. Sample-sizes for the proportional hazards regression model. Biometrics. 39:1983;499-503.
14. Kaplan E.L., Meier R. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemo Rep. 50:1966;163-170.
16. Cox D.R. Regression model and life tables (with discussion). J R Stat Soc B. 34:1972;187-220.
17. Snedcor G.W., Cochran W.G. Statistical methods. 6th ed:1967;The Iowa State University Press, Ames, Iowa.
18. Pocock S.J. Clinical trials a practical approach . 1998;John Wiley and Sons, Inc, New York.
19. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data. 1980;John Wiley and Sons, Inc, New York.
20. Thoms W.W., Eifel P.J., Smith T.L., Morris M., Delclos L., Wharton J.T., et al. Bulky endocervical carcinoma a 23-year experience . Int J Radiat Oncol Biol Phys. 23:1992;491-499.
21. Eifel P.J., Morris M., Wharton J.T., Oswald M.J. Adenocarcinoma of the uterine cervix. Cancer. 65:1990;2507-2514.
22. Mendenhall W.M., McCarty P.J., Morgan L.S., Chafe W.E., Million R.R. Stage IB or IIA-B carcinoma of the intact uterine cervix ≥ 6 cm in diameter is adjunctive hysterectomy beneficial? Cancer. 53:1984;2649-2654.
23. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix a Gynecologic Oncology Group study . Gynecol Oncol. 38:1990;352-357.
24. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., Larson J.E., Fowler W.C. Carcinoma of the cervix treated with irradiation therapy I a multivariate analysis of prognostic variables in the Gynecologic Oncology Group . Cancer. 67:1991;2776-2785.
25. Perez C.A., Grigsby P.W., Camel H.M., Galakatos A.E., Mutch D., Lockett M.A. Irradiation alone or combined with surgery in stage IB, IIA and IIB carcinoma of the uterine cervix update of a nonrandomized comparison . Int J Radiat Oncol Biol Phys. 31:1995;703-716.
26. Maruyama Y., van Nagell J.R., Yoneda J., Donaldson E., Gallion H.H., Higgins R., et al. Dose-response and failure pattern for bulky or barrel-shaped stage IB cervical cancer treated by combined photon irradiation and extrafascial hysterectomy. Cancer. 63:1989;70-76.
27. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L., et al. Weekly cisplatin chemotherapy during irradiation improves survival and reduces relapses for patients with bulky stage IB cervical cancer treated with irradiation and adjuvant hysterectomy results of a randomized Gynecologic Oncology Group trial . N Engl J Med. 340:1999;1154-1161.
28. Rose P.G., Bundy B.N., Thigpen J.T., Deppe G., Maiman M.A., Clarke-Pearson D.L., et al. Concomitant cisplatin-based chemoradiation improves progression-free and overall survival in advanced cervical cancer results of a randomized Gynecologic Oncology Group study . N Engl J Med. 340:1999;1144-1153.
29. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes a Gynecologic Oncology Group and Southwest Oncology Group study . J Clin Oncol. 17:1999;1339-1348.
30. Peters W.A. III, Liu P.Y., Barrett R.J. II, Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 18:2000;1606-1613.
31. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levelback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143.